ALPS Advisors’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.85M | Sell |
65,024
-22,340
| -26% | -$634K | 0.01% | 377 |
|
|
2025
Q1 | $2.58M | Sell |
87,364
-9,111
| -9% | -$269K | 0.02% | 311 |
|
|
2024
Q4 | $2.81M | Buy |
96,475
+8,408
| +10% | +$245K | 0.02% | 297 |
|
|
2024
Q3 | $4.04M | Buy |
88,067
+13,460
| +18% | +$618K | 0.03% | 261 |
|
|
2024
Q2 | $3.05M | Buy |
74,607
+18,380
| +33% | +$751K | 0.02% | 283 |
|
|
2024
Q1 | $1.43M | Buy |
56,227
+5,554
| +11% | +$142K | 0.01% | 409 |
|
|
2023
Q4 | $459K | Sell |
50,673
-4,057
| -7% | -$36.7K | ﹤0.01% | 621 |
|
|
2023
Q3 | $349K | Buy |
54,730
+2,674
| +5% | +$17.1K | ﹤0.01% | 661 |
|
|
2023
Q2 | $577K | Buy |
52,056
+5,406
| +12% | +$60K | 0.01% | 586 |
|
|
2023
Q1 | $716K | Buy |
46,650
+9,731
| +26% | +$149K | 0.01% | 528 |
|
|
2022
Q4 | $819K | Buy |
36,919
+8,416
| +30% | +$187K | 0.01% | 519 |
|
|
2022
Q3 | $465K | Sell |
28,503
-1,022
| -3% | -$16.7K | ﹤0.01% | 605 |
|
|
2022
Q2 | $429K | Buy |
+29,525
| New | +$429K | ﹤0.01% | 637 |
|